Volume 28 - Number 1 | July 2009
| July Issue in PDF Format |
| Recalls of Foreign-Made Products Lead to Increased Scrutiny at Home By Kimberly H. Clancy and Brendan P. Sheehey The increased regulation of safety standards, testing, certifications of compliance, and advertising will likely result in a significant increase in the number of foreign product recalls. This, in turn, will yield increased litigation in the future. Here's why. |
| Practice Tip: Reducing Product Liability Litigation Costs By Ronald J. Levine and Jennifer Smith Finnegan This article poses ten questions in-house corporate counsel should ask themselves when they are preparing to defend a case and are in the process of retaining outside counsel. |
| NJ Judge Won’t Certify Class Action By Vioxx Users By Charles Toutant In March, an Atlantic County, NJ, judge denied a request to certify a class action against Merck & Co. on behalf of consumers for their out-of-pocket expenses for the painkiller Vioxx, which was withdrawn from the market in 2004 after a medical study linked it to heart disease. |
| Two Federal Courts Reject Medical Monitoring Class Actions By Gregg Nunziata Recently, two federal courts rejected certification in three putative "medical monitoring" class actions that were brought against E.I. DuPont de Nemours and Company in West Virginia and New Jersey. These are significant rulings in the still developing field of "medical monitoring," and indicate the limits of class certification based on medical monitoring theories of recovery |
| Proposed Amendments to Federal Rules Would Limit Expert Witness Disclosures By Leyla Mujkic, Hesham M. Sharawy and Daniel J. Herling Rule 26 of the Federal Rules of Civil Procedure incentivizes a partys attorney to get creative in his efforts to prevent disclosure of his communications with the partys expert ... The results of the rule have been costly and often lead to the discovery of information that is only marginally relevant to any genuine issue in dispute. |
| Hotline Recent rulings of interest to you and your practice. |






